These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3784403)

  • 1. [Cancer of the prostate with metastases to the bone marrow].
    Tachev S; Ormanov I; Slavov Ch
    Khirurgiia (Sofiia); 1986; 39(5):96-7. PubMed ID: 3784403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hematologic manifestations of cancers of the prostate].
    Piot G; Finaud M; Bayle C; Subtil E; Droz JP
    J Urol (Paris); 1985; 91(9):617-22. PubMed ID: 3834002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.
    Haq M; Goltzman D; Tremblay G; Brodt P
    Cancer Res; 1992 Sep; 52(17):4613-9. PubMed ID: 1511429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphological and histomorphometric study of bone and bone marrow metastases of prostatic adenocarcinoma].
    Cambon C; Pinel B; Le Loët X; Tayot J; Basuyau JP; Deshayes P
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):643-50. PubMed ID: 6523015
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenging problems in advanced malignancy: Case 2. Disseminated intravascular coagulation in metastatic hormone-refractory prostate cancer.
    Kampel LJ
    J Clin Oncol; 2003 Aug; 21(16):3170-1. PubMed ID: 12915609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study on prostate cancer initially presenting with disseminated intravascular coagulation syndrome].
    Ohtake N; Kurita S; Fukabori Y; Imai K; Yamanaka H; Nakata S; Sato J; Kurihara J; Mashimo M; Sekihara T; Saruki K; Kawashima K; Takahashi H; Tsuchiya K; Okabe K; Jimbo S; Kurita M
    Hinyokika Kiyo; 1998 Jun; 44(6):387-90. PubMed ID: 9719936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of extremely advanced prostate cancer presenting hemolytic jaundice.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1994 Mar; 40(3):261-3. PubMed ID: 8178748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does bladder neck carcinoma exhibit the same propensity for osseous metastases as prostatic carcinoma? (A comparative bone marrow cytological study).
    Nawaz SK; Rao MS; Bapna BC; Das KC; Gupta S; Vaidyanathan S; Jain S
    Indian J Cancer; 1979 Jun; 16(2):50-3. PubMed ID: 546731
    [No Abstract]   [Full Text] [Related]  

  • 9. Trousseau's syndrome in a patient with metastatic prostate cancer.
    Rodriguez R; Walsh PC
    J Urol; 2000 Jun; 163(6):1877. PubMed ID: 10799213
    [No Abstract]   [Full Text] [Related]  

  • 10. A patient with prostate cancer and multiple myeloma-diagnostics and possible association of both diseases.
    Sučić M; Bišof V; Cačić M; Kinda SB; Kolenc D; Ljubić N; Sučić T; Potočki K
    Ann Diagn Pathol; 2012 Dec; 16(6):515-20. PubMed ID: 21840230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow.
    Koizumi K; Haseyama Y; Machino R; Sato Y; Sawada K; Koike T
    J Urol; 2002 Sep; 168(3):1101-2. PubMed ID: 12187236
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: case report and review of the literature.
    Sarver RG; Dalkin BL; Ahmann FR
    Urology; 1997 May; 49(5):781-5. PubMed ID: 9145992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DCE-MRI postprocessing techniques to assess metastatic bone marrow in patients with prostate cancer.
    Michoux N; Simoni P; Tombal B; Peeters F; Machiels JP; Lecouvet F
    Clin Imaging; 2012; 36(4):308-15. PubMed ID: 22726969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report.
    Kulić A; Cvetković Z; Libek V
    Vojnosanit Pregl; 2016 Sep; 73(9):877-80. PubMed ID: 29320623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow necrosis by diffuse metastatic intravascular obstruction.
    Ricci P; Bandini G; Baccarani M; Bazzocchi F; Martinelli G; Tura S
    Haematologica; 1982 Oct; 67(5):754-9. PubMed ID: 6816686
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone metastases from prostate cancer without elevated prostate-specific antigen levels: diagnosis by anti-PSA immunostaining.
    Berthelot JM; Gouin F; Denis M; Nomballais MF; Maugars Y; Blaive-Cervi S; Prost A
    Rev Rhum Engl Ed; 1995 Jan; 62(1):54-5. PubMed ID: 7540487
    [No Abstract]   [Full Text] [Related]  

  • 17. The if's, and's, or but's regarding bisphosphonates for prostate cancer.
    Wilt TJ; Ensrud KE
    J Natl Cancer Inst; 2007 May; 99(10):744-5. PubMed ID: 17505065
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone and bone marrow metastases of prostatic adenocarcinoma: the serum level of prostate-specific antigen may be normal].
    Marlier S; Durupt S; de Jaureguiberry JP; Marlier-Civatte M; Peybere B; Jaubert D
    Presse Med; 1996 May 4-11; 25(16):777. PubMed ID: 8692758
    [No Abstract]   [Full Text] [Related]  

  • 19. Disseminated intravascular coagulation in a patient with metastatic prostate cancer: fatal outcome following strontium-89 therapy.
    Leong C; McKenzie MR; Coupland DB; Gascoyne RD
    J Nucl Med; 1994 Oct; 35(10):1662-4. PubMed ID: 7931669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypocalcaemia associated with extensive osteoblastic metastases in a patient with prostate cancer.
    Fokkema MI; de Heide LJ; van Schelven WD; Hamdy NA
    Neth J Med; 2005 Jan; 63(1):34-7. PubMed ID: 15719851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.